NRX Pharmaceuticals, Inc. ·

NRXPW 8-K 2026-01-16

NRX Pharmaceuticals, Inc. (NRXPW) 8-K dated 2026-01-16 — accession 0001437749-26-001455. This URL is the filing, not the NRXPW hub.

NRX Pharmaceuticals, Inc. (NRXPW) common stock listed on NASDAQ.

NRX Pharmaceuticals, Inc. filed a 8-K on 2026-01-16. Accession 0001437749-26-001455.

Cached items: 3.01, 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.

Not investment advice. The NRXPW SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR